[{"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76661", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0603-2017", "product_description": "Buffered Lidocaine, 1%, In Sodium Bicarbonate 8.4%, 1 mL Total Volume in a 3 mL syringe, Local anesthetic use, Rx only, PharMEDium, Product code 2K2466", "product_quantity": "3879 syringes", "reason_for_recall": "Labeling; Label Mixup; outer packaging is incorrectly labeled as Buffered Lidocaine 1% instead of correctly as Buffered Lidocaine 0.9%", "recall_initiation_date": "20170127", "center_classification_date": "20170315", "termination_date": "20170316", "report_date": "20170322", "code_info": "Lot Numbers:  170110030M, 170110029M and 170070058M"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "1 vial", "code_info": "Lot # t01-31-2017@132, Exp 5/2/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "PYRIDOXAL-5-PHOS 10ML MDV 100MG/ML INJ, Injection, 100mg/mL, Rx only, 10mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0776-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Houston", "address_1": "1304 S Loop W", "reason_for_recall": "Labeling; Error on Declared Strength; product description incorrectly states HCG 7500 units instead of 5000 units. The primary panel is correct", "address_2": "", "product_quantity": "112 bottles", "code_info": "Lots: 07272016:03 Expiration Date: 01/23/2017 and 09142016:88 Expiration Date: 03/07/2017", "center_classification_date": "20170109", "distribution_pattern": "AZ and WA", "state": "TX", "product_description": "HCG-Vitamin B12 5000 IU-8 mg in 10 mL vial, Rx only, For Sub-Q & IM Injection, Pharm D Solutions, Loop West Houston, TX --- NDA 69699-1723-20", "report_date": "20170118", "classification": "Class III", "openfda": {}, "recalling_firm": "Pharm D Solutions, LLC", "recall_number": "D-0427-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "75552", "termination_date": "20170511", "more_code_info": "", "recall_initiation_date": "20161012", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0345-2017", "product_description": "Ceftazidime, Lyophilized, Ophthalmic 2.25% Kit, Rx only, Compounded by Wells Pharmacy, Ocala , FL", "product_quantity": "46 kits (number of vials per kit vary by prescription)", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known kit lot code: 06062016@118.  Vial lot code 05272016@47"}, {"status": "Terminated", "city": "Chicago", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77959", "recalling_firm": "Bella Pharmaceuticals, Inc.", "address_1": "3101 W Devon Ave", "address_2": "N/A", "postal_code": "60659-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within USA", "recall_number": "D-1147-2017", "product_description": "Methylcobalamin 10mg, (1mg/ml), 30 mL vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.", "product_quantity": "30 vials", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20170815", "center_classification_date": "20170912", "termination_date": "20180423", "report_date": "20170920", "code_info": "Lot #: 070717MC, Exp. 1/7/18"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77465", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "NY, GA, NV, CA, KY, TX", "recall_number": "D-0919-2017", "product_description": "ESTRONE USP, packaged in a) 1g bottle (NDC: 58597-8049-2), c) 5g bottle (NDC: 58597-8049-3), d) 25g bottle (NDC: 58597-8049-4), For Prescription Compounding, RX Only, Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC, 6650 Highland Road, Waterford, MI 48327", "product_quantity": "1g=1 bottle; 5g=4 bottle; 25g=3 bottles", "reason_for_recall": "cGMP Deviations; lack of quality assurance.", "recall_initiation_date": "20170417", "center_classification_date": "20170615", "termination_date": "20180531", "report_date": "20170621", "code_info": "Lots:  052915-1, 052915-2, exp 5/5/2017"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0563-2017", "product_description": "MALEK'S MAGIC (retinoic acid 0.05%, hydroquinone 6%, kojic acid 3%, hydrocortisone 1%), Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "South Beloit", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "78359", "recalling_firm": "Precision Dose Inc.", "address_1": "722 Progressive Ln", "address_2": "N/A", "postal_code": "61080-2616", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0057-2018", "product_description": "Carbamazepine Oral Suspension USP, 100 mg/5 mL, 5 mL Unit Dose Cups (NDC 68094-301-59), packaged in 10-count cups per tray, 3 trays per case containing a total of 5 mL x 30 Unit Dose Cups per case (NDC 68094-301-62), Rx only, Pkg: Precision Dose, Inc., S. Beloit, IL  61080.", "product_quantity": "801 cases", "reason_for_recall": "Subpotent Drug: low out of specification results.", "recall_initiation_date": "20170925", "center_classification_date": "20171101", "termination_date": "20180423", "report_date": "20171108", "code_info": "Lot number: 500105, Exp 04/30/18"}, {"status": "Terminated", "city": "Rochester", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206586"], "brand_name": ["BUPRENORPHINE HYDROCHLORIDE"], "generic_name": ["BUPRENORPHINE HYDROCHLORIDE"], "manufacturer_name": ["Endo USA, Inc."], "product_ndc": ["42023-179"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["BUPRENORPHINE HYDROCHLORIDE"], "rxcui": ["238129"], "spl_id": ["105d22a7-a7bb-4d60-8714-ad0838bff0e2"], "spl_set_id": ["34767dda-ce52-4f98-a45f-bb5cee0cd5e6"], "package_ndc": ["42023-179-05", "42023-179-01"], "is_original_packager": [true], "unii": ["56W8MW3EN1"]}, "product_type": "Drugs", "event_id": "77169", "recalling_firm": "PAR Sterile Products LLC", "address_1": "870 Parkdale Rd", "address_2": "N/A", "postal_code": "48307-1740", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0698-2017", "product_description": "Buprenorphine HCI Injection, 0.3 mg/mL, 1 mL Single Dose Vial (NDC 42023-179-01), packaged in 1 mL x 5 Single Dose Vials per carton (NDC 42023-179-05), Rx Only, Distributed by: Par Pharmaceuticals Companies, Inc., Spring Valley, NY  10977.", "product_quantity": "122,469 cartons", "reason_for_recall": "Crystallization: due to the presence of white, crystalline particulates, adhered to the side and bottom of the glass vials, which are comprised of principally dextrose and the buprenorphine active component.", "recall_initiation_date": "20170428", "center_classification_date": "20170509", "termination_date": "20180329", "report_date": "20170517", "code_info": "Lot #: 821102, 821103, Exp 01/18; 821104, 821106, 821107, Exp 02/18; 821108, Exp 03/18; 821884, 821885, Exp 07/18; 821886, 821887, Exp 08/18; 822767, Exp 09/18; 824183, Exp 10/18."}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77770", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1031-2017", "product_description": "PHENYLephrine 50 mg in 0.9% Sodium Chloride 250 mL, Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0820-40", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; product has the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170726", "termination_date": "20190501", "report_date": "20170802", "code_info": "Lots: 20170512@6 BUD: 8/10/2017; 20170511@56 BUD: 8/9/2017"}, {"country": "United States", "city": "Little Rock", "address_1": "8821 Knoedl Ct", "reason_for_recall": "Lack of assurance of sterility: Product bags leaking at seam.", "address_2": "", "product_quantity": "56 bags", "code_info": "LOT  # 20170508@48, Use By: 08/06/17; 20170505@19, Use By: 08/03/17", "center_classification_date": "20170531", "distribution_pattern": "Nationwide in the USA", "state": "AR", "product_description": "morphine sulfate in 0.9% Sodium Chloride injectable, 1 mg per mL, Total Volume 100 mL,  Single Dose Container bag, (Total morphine Dose 100 mg/ 100 mL), Preservative Free (Contains Sulfites), Rx only, SCA Pharmaceuticals, 8821 Knoedl Ct, Little Rock, AR  72205, NDC 70004-0100-55", "report_date": "20170607", "classification": "Class II", "openfda": {}, "recalling_firm": "SCA Pharmaceuticals", "recall_number": "D-0871-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77314", "termination_date": "20180329", "more_code_info": "", "recall_initiation_date": "20170518", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Miami Lakes", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "76681", "recalling_firm": "Complete Pharmacy and Medical Solutions LLC", "address_1": "5829 NW 158th St", "address_2": "N/A", "postal_code": "33014-6721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0918-2017", "product_description": "Human Chorionic Gonadotropin, 15,000 IU per vial, lyophilized for injection, Rx only,  Complete Pharmacy & Medical Solutions, Miami Lakes, FL 33014", "product_quantity": "49 vials", "reason_for_recall": "Non-sterility - presence of bacteria confirmed by outside laboratory after day 14.", "recall_initiation_date": "20160402", "center_classification_date": "20170613", "report_date": "20170621", "code_info": "Lot # 22016, Exp 1/30/2017"}, {"status": "Terminated", "city": "Hawthorne", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA062364"], "brand_name": ["NYSTATIN AND TRIAMCINOLONE ACETONIDE"], "generic_name": ["NYSTATIN AND TRIAMCINOLONE ACETONIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["51672-1263", "51672-1272"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["NYSTATIN", "TRIAMCINOLONE ACETONIDE"], "rxcui": ["1053697", "1053753"], "spl_id": ["395e7f1c-ecc8-31cf-e063-6294a90aef62"], "spl_set_id": ["2fd97fc5-cae5-43dd-a3c7-c9a03876153e"], "package_ndc": ["51672-1272-1", "51672-1272-2", "51672-1272-3", "51672-1263-1", "51672-1263-2", "51672-1263-3"], "is_original_packager": [true], "nui": ["N0000175498", "M0017172", "N0000175576", "N0000175450"], "pharm_class_epc": ["Polyene Antifungal [EPC]", "Corticosteroid [EPC]"], "pharm_class_cs": ["Polyenes [CS]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["BDF1O1C72E", "F446C597KA"]}, "product_type": "Drugs", "event_id": "76954", "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "address_1": "3 Skyline Dr", "address_2": "N/A", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0676-2017", "product_description": "Nystatin and Triamcinolone Acetonide Cream, USP, 100,000 USP nystatin units and 1 mg triamcinolone acetonide, distributed in a) 15 grams (NDC 51672-1263-1), b) 30 grams (NDC 51672-1263-2)  and c) 60 grams (NDC 51672-1263-3) tubes, Rx only, TARO label;  Mfd. by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1 -- Dist. by: Taro Pharmaceuticals U.S.A. Inc., Hawthorne, NY 10532", "product_quantity": "278,304 tubes", "reason_for_recall": "Failed Content Uniformity Specifications; out-of-specification (OOS) results 18-month stability", "recall_initiation_date": "20170328", "center_classification_date": "20170420", "termination_date": "20190617", "report_date": "20170426", "code_info": "a) 15 g: Lot B505118501, exp. date January 2018;   b) 30 g: Lot B504918500, exp. date January 2018;  c) 60 g: Lots: I416616979, exp. date August 2017,                      I416716979, exp. date August 2017 and                     D504519119, exp. date March 2018"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0275-2017", "product_description": "Myers Cocktail #5 (Ascorbic Acid 2000 mg + Magnesium Chloride 1000 mg + Calcium Gluconate (Anhydrous) 200 mg + Pyridoxine HCL 100 mg +  Dexpanthenol 252 mg + Methylcobalamin 2 mg + Thiamine HCL 100 mg + Riboflavin-5-Phosphate Sod 2 mg + Folic Acid 1 mg + Vitamin E Succinate 10 IU + Vitamin A Acetate 100 IU/10-mL), (10 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "21 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.     Known lot codes (Exp Date): 07182016A (12/31/2016)"}, {"status": "Terminated", "city": "Salem", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78462", "recalling_firm": "Ridge Properties, LLC", "address_1": "4995 Ridge Dr NE", "address_2": "N/A", "postal_code": "97301-7475", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product distributed throughout United States.", "recall_number": "D-0086-2018", "product_description": "Extra Strength Naturally HL Bed Sore Relief Cream with Added Lidocaine, (lidocaine HCL 4%), 1/2 oz Balm(NDC 69804-008-06), 1 oz Balm (NDC 69804-008-05), 2 oz Balm(NDC 69804-008-02), and 4 oz Balm(NDC 69804-008-03), Manufactured by Pain Relief Naturally, www.Naturally HL.com", "product_quantity": "N/A", "reason_for_recall": "GMP Deviations: inadequate manufacturing control processes", "recall_initiation_date": "20171103", "center_classification_date": "20171121", "termination_date": "20190114", "report_date": "20171129", "code_info": "All batches and lots, exp 10/17/2018. Not all batches were assigned lot numbers"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77770", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1014-2017", "product_description": "fentaNYL 2 mcg/mL + BUPIvacaine 0.1% PF in 0.9% NS 250 mL, Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0230-40", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; product has the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170726", "termination_date": "20190501", "report_date": "20170802", "code_info": "Lots: 20170502@47 BUD: 7/31/2017; 20170502@56 BUD: 7/31/2017; 20170505@26 BUD: 8/3/2017; 20170506@25 BUD: 8/4/2017"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "6 vials total (5/5mL vials and 1/10mL vial)", "code_info": "Lot # t02-09-2017@79, Exp 5/14/2017; t02-22-2017@91, Exp 5/24/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "TESTOST AQ MDV  50MG/ML INJ, Injection, 50mg/mL, Rx only, packaged in 5mL and 10mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0783-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0296-2017", "product_description": "Taurine 50 mg/mL, (30 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "90 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 06282016C (12/25/2016), 10242016A (10/27/2016), 10212016A (10/24/2016)."}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75650", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0462-2017", "product_description": "Lactulose Solution, USP 20 g/30 mL, 50 unit dose cups of 30 mL per case, Rx only, Manufactured by VistaPharm, Largo, FL 33771, NDC No. 66689-038-50.", "product_quantity": "18,437 unit dose cups", "reason_for_recall": "CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.", "recall_initiation_date": "20170118", "center_classification_date": "20170202", "termination_date": "20210826", "report_date": "20170208", "code_info": "Lot No. 422800 (1Exp. 0/17), 430500 (Exp. 12/17), 424000 (Exp. 10/17), 412500 (Exp. 07/17), 405500 (Exp. 05/17), 414900 (Exp. 09/17)", "more_code_info": ""}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Hydromorphone HCl all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0810-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Hyderabad", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA203052"], "brand_name": ["LEVETIRACETAM"], "generic_name": ["LEVETIRACETAM ORAL"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-574"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVETIRACETAM"], "rxcui": ["403884"], "spl_id": ["230b2750-8691-425b-9fe3-176b46e01e78"], "spl_set_id": ["0bc8468f-832c-4e71-95a2-db464d4d54bc"], "package_ndc": ["31722-574-47"], "is_original_packager": [true], "upc": ["0331722574471"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["44YRR34555"]}, "product_type": "Drugs", "event_id": "78287", "recalling_firm": "Hetero Labs, Ltd. - Unit III", "address_1": "Plot 22-110, Part Ii, Ida", "address_2": "Rangareddy, Jeedimetla", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ", "recall_number": "D-0099-2018", "product_description": "Levetiracetam Oral Solution, USP, 100 mg/mL, packaged in a 16 fl oz (473 mL) bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Jeedimetla,Hyderabad - 500 055, India, NDC 31722-574-47", "product_quantity": "4050 bottles", "reason_for_recall": "Presence of foreign substance (screw)", "recall_initiation_date": "20171012", "center_classification_date": "20171129", "termination_date": "20200903", "report_date": "20171206", "code_info": "Lot # E170346, Exp 02/19"}, {"status": "Terminated", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77647", "recalling_firm": "ImprimisRx CA, Inc., dba ImprimisRx", "address_1": "9257 Research Dr", "address_2": "N/A", "postal_code": "92618-4286", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-1132-2017", "product_description": "Timolol-Latanoprost PF Solution (0.5-0.005)%, Ophthalmic Drops, Sterile 5ml Bottle, Compounded for a licensed professional or patient use, imprimisRx, Irvine, CA", "product_quantity": "16 bottles", "reason_for_recall": "Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier", "recall_initiation_date": "20170623", "center_classification_date": "20170907", "termination_date": "20190114", "report_date": "20170913", "code_info": "04042017@34B, 10/01/2017"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78048", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1177-2017", "product_description": "Sterile Water for Injection, USP Single Dose 100 mL vials, Rx only, Manufactured by Hospira, Inc., Lake Forest, IL 60045 USA for Genentech, Inc., South San Francisco, CA 94080-4990. NDC 50242-901-24", "product_quantity": "18,725 vials", "reason_for_recall": "Non-Sterility: cracked or chipped glass at the neck of Sterile Water for Injection vials.", "recall_initiation_date": "20170901", "center_classification_date": "20170922", "termination_date": "20200124", "report_date": "20171004", "code_info": "Lot: 63-075-DK Exp. FEB 2019"}, {"status": "Terminated", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018161"], "brand_name": ["ACETIC ACID"], "generic_name": ["ACETIC ACID"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-2304"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["IRRIGATION"], "substance_name": ["ACETIC ACID"], "rxcui": ["307707"], "spl_id": ["ab98b143-e9d6-4869-9abf-708ec1004f57"], "spl_set_id": ["dd45cee3-9938-4dad-a5e1-1dd4baea85a9"], "package_ndc": ["0264-2304-00", "0264-2304-10"], "is_original_packager": [true], "unii": ["Q40Q9N063P"]}, "product_type": "Drugs", "event_id": "78767", "recalling_firm": "B. Braun Medical Inc", "address_1": "2525 McGaw Ave", "address_2": "", "postal_code": "92614-5841", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0112-2018", "product_description": "0.25% Acetic Acid Irrigation USP, 500 mL Plastic Irrigation Container (PIC), B. Braun Medical Inc. Irvine CA 92614-5895 USA, NDC 0264-2304-10", "product_quantity": "2,576 containers", "reason_for_recall": "Presence of Particulate Matter: identified as polyethylene, which is consistent with the material used to manufacture the contain cap", "recall_initiation_date": "20171215", "center_classification_date": "20171220", "termination_date": "20181018", "report_date": "20171227", "code_info": "Lot #: J7N965, Exp. 10/31/2020", "more_code_info": ""}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Magnesium Sulfate all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0848-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Plattsburgh", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76873", "recalling_firm": "Medisca, Inc.", "address_1": "661 State Route 3 Unit C", "address_2": "N/A", "postal_code": "12901-6531", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Australia, Bahamas, Italy, Singapore, Thailand, United Kingdom", "recall_number": "D-0665-2017", "product_description": "ESTRADIOL, USP (Hemihydrate)(Micronized), in a) 100 mg (NDC 38779-0869-07), b) 1 g (NDC 38779-0869-06), c) 5 g (NDC 38779-0869-03), d) 10 g (NDC 38779-0869-01), e) 25 g (NDC 38779-0869-04), f) 100 g (NDC 38779-0869-05) , g) 500 g (NDC 38779-0869-08), h) 1 Kg (NDC 38779-0869-09)  bottles, Packed by MEDISCA INC. PLATTSBURGH, NY 12901; Product Code 0869", "product_quantity": "N/A", "reason_for_recall": "cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection", "recall_initiation_date": "20170403", "center_classification_date": "20170412", "termination_date": "20190618", "report_date": "20170419", "code_info": "a) 137169/F   b) 129670/G, 129670/K, 130942/G, 130942/L, 131429/G, 131430/G, 137169/E  c)  129670/F,129670/J,  130942/F, 130942/K 131429/F, 131430/F, 137169/D,  d) 129670/E, 129670/I,130942/E, 130942/J,131429/E, 131430/E, 137169/C  e) 129670/D, 129670/H, 130942/D, 130942/I, 131429/D, 131430/D, 131430/H, 137169/B  f) 129670/C, 130942/C, 130942/H, 131429/C, 131430/C, 137169/A, 137169/F  g) 129670/B,  130942/B,  131429/B, 131430/B   h) 129670/A, 130942/A ,131429/A, 131430/A", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76435", "recalling_firm": "Sandoz Inc", "address_1": "100 College Rd W", "address_2": "N/A", "postal_code": "08540-6604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0481-2017", "product_description": "Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 1 patch per pouch (NDC 66758-208-58), packaged in 4-count patches per carton (NDC 66758-208-54), Rx Only, Manufactured by ALZA Corporation, Vacaville, CA  95688 for Sandoz Inc., Princeton, NJ  08540.", "product_quantity": "157,922 cartons", "reason_for_recall": "Labeling: Incorrect Instructions:outer carton contains the incorrect instructions for Step 2 stating \"Do cut the patch\" rather than the correct instructions of \"Do not cut the patch\". The pouch containing the patch is labeled correctly.", "recall_initiation_date": "20170202", "center_classification_date": "20170217", "termination_date": "20171024", "report_date": "20170301", "code_info": "Lot #: 6323Q11, 6328Q11, Exp 06/19; 6355Q11, Exp 07/19"}, {"status": "Terminated", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77391", "recalling_firm": "Bausch & Lomb, Inc.", "address_1": "8500 Hidden River Pkwy", "address_2": "N/A", "postal_code": "33637-1014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0899-2017", "product_description": "NasalCrom (cromolyn sodium) Nasal Spray, USP, 5.2 mg per spray, 200 metered sprays, 0.88 FL OZ (26 mL) metered spray pump bottle, Distributed by: Medtech Products, Inc., Tarrytown, NY  10591, UPC 8 148332 01101 7.", "product_quantity": "44,520 bottles", "reason_for_recall": "CGMP Deviations: Possibility of the presence of microbial contamination in the water used to manufacture this product lot.", "recall_initiation_date": "20170606", "center_classification_date": "20170609", "termination_date": "20190501", "report_date": "20170621", "code_info": "Lot: 253211, Exp 12/18"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77770", "recalling_firm": "SCA Pharmaceuticals", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1017-2017", "product_description": "Hydromorphone 0.5 mg/mL in 0.9% Sodium Chloride 1 mL Fill in 3 mL BD syringe, Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0302-05", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; product has the potential to leak.", "recall_initiation_date": "20170714", "center_classification_date": "20170726", "termination_date": "20190501", "report_date": "20170802", "code_info": "Lot: 20170508@75 BUD: 8/6/2017"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0406-2017", "product_description": "TitanMax-MIC/12/CA/CH/L/D Injectable 25 mg/50 mg/50/0.5 mg/50 mg/25 mcg/25 mg/25 mg/mL, 30 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "18 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 07212016@15."}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200834"], "brand_name": ["VENLAFAXINE HYDROCHLORIDE"], "generic_name": ["VENLAFAXINE HYDROCHLORIDE"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-527", "65862-528", "65862-697"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VENLAFAXINE HYDROCHLORIDE"], "rxcui": ["313581", "313583", "313585"], "spl_id": ["d3f9b554-05be-484f-b9e7-5c8e6b2de9c9"], "spl_set_id": ["85d3ce8b-8966-45d9-bdaf-f6f0475096e1"], "package_ndc": ["65862-527-47", "65862-527-30", "65862-527-90", "65862-527-01", "65862-527-99", "65862-527-59", "65862-527-10", "65862-528-47", "65862-528-30", "65862-528-90", "65862-528-01", "65862-528-99", "65862-528-35", "65862-528-10", "65862-697-47", "65862-697-30", "65862-697-90", "65862-697-01", "65862-697-05", "65862-697-26", "65862-697-10"], "is_original_packager": [true], "upc": ["0365862528476", "0365862527479"], "unii": ["7D7RX5A8MO"]}, "product_type": "Drugs", "event_id": "76325", "recalling_firm": "Aurobindo Pharma USA Inc", "address_1": "666 Plainsboro Rd Ste 210", "address_2": "N/A", "postal_code": "08536-3004", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0474-2017", "product_description": "Venlafaxine Hydrochloride extended release capsules, 37.5 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 072 India, NDC 65862-527-30", "product_quantity": "47,040 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Some bottles contain  punctured, and/or clumped/melted capsules.", "recall_initiation_date": "20161222", "center_classification_date": "20170213", "termination_date": "20190319", "report_date": "20170222", "code_info": "Lot #: VI3716010-A, Exp. 04/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78063", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-0049-2018", "product_description": "Oxytocin 40 units added to 1000 mL Lactated Ringer's USP in 1000 mL bag Rx Only, Compounded by PharMEDium Services, LLC. 12620 W. Airport Blvd. #130 Sugar Land, TX 77478, NDC# 71019-245-04", "product_quantity": "42 bags", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20170901", "center_classification_date": "20171025", "termination_date": "20200124", "report_date": "20171101", "code_info": "All unexpired lots."}, {"status": "Terminated", "city": "Chandler", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78227", "recalling_firm": "Banner Pharmacy Services, LLC", "address_1": "7300 W Detroit St", "address_2": "N/A", "postal_code": "85226-2410", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the US", "recall_number": "D-0028-2018", "product_description": "Norepinephrine Bitartrate16 mg added to 0.9% Sodium Chloride 250 mL bag, Rx Only,  Banner Health Compounding Pharmacy 7300 W Detroit St Chandler, AZ 85226, NDC 7025014801", "product_quantity": "481 bags", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20171010", "center_classification_date": "20171023", "termination_date": "20180809", "report_date": "20171101", "code_info": "Lot #: 072717S4,  Exp 10/26/2017; 080917S2, Exp 11/8/2017;  082517S1, Exp 11/24/2017"}, {"status": "Terminated", "city": "Pine Brook", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76664", "recalling_firm": "Alvogen, Inc", "address_1": "10 Bloomfield Ave Bldg B Ste 2", "address_2": "N/A", "postal_code": "07058-9743", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0627-2017", "product_description": "Nifedipine Extended-Release Tablets, 30 mg, 100-count bottles, Rx Only, Manufactured for Alvogen Inc. Pine Brook, NJ 07058 USA, NDC 47781-368-01.", "product_quantity": "N/A", "reason_for_recall": "Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib", "recall_initiation_date": "20170307", "center_classification_date": "20170404", "termination_date": "20171215", "report_date": "20170412", "code_info": "Lot #: BXH1P22, BXH1P21A, BXH1P21, BXH1P31, BXH1P21B, Exp. 11/2017; BXH6EL1, BXH66A1, BXH6EN1, BXH6EP1, BXH6ER1, Exp. 06/2018; BXH81K1A, BXHBJD1A, Exp. 10/2018"}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021591"], "brand_name": ["RIOMET"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["10631-206", "10631-238"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["861025", "861027"], "spl_id": ["8ed86d67-8a49-4334-82c4-1dbf6a489d3b"], "spl_set_id": ["05d4df4b-dfe8-4828-b423-a3d4f2c4114a"], "package_ndc": ["10631-238-01", "10631-238-02", "10631-206-01", "10631-206-02"], "is_original_packager": [true], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "78217", "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "address_1": "270 Prospect Plains Rd", "address_2": "N/A", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0109-2018", "product_description": "Riomet (metformin hydrochloride) Oral Solution Cherry Flavored 500 mg /5 mL, 4 fl. oz. (NDC 10631-206-01) and 16 fl. oz. (NDC 10631-206-02) HDPE bottles,  Rx only, Manufactured for: Ranbaxy Laboratories Inc. Jacksonville, FL 32257 USA, Distributed by: Sun Pharmaceutical Industries, Cranbury, NJ 08512", "product_quantity": "N/A", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "recall_initiation_date": "20170418", "center_classification_date": "20171213", "termination_date": "20180530", "report_date": "20171220", "code_info": "A lot # 160031A, A160031B; Exp. 11/17"}, {"status": "Terminated", "city": "Pine Brook", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76664", "recalling_firm": "Alvogen, Inc", "address_1": "10 Bloomfield Ave Bldg B Ste 2", "address_2": "N/A", "postal_code": "07058-9743", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0633-2017", "product_description": "Adalat CC (nifedipine) Extended-Release Tablets, 30 mg, 100-count bottles, Rx Only, Manufactured for   Almatica Pharma Inc. Pine Brook, NJ 07058 USA, NDC 5242749401", "product_quantity": "N/A", "reason_for_recall": "Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib", "recall_initiation_date": "20170307", "center_classification_date": "20170404", "termination_date": "20171215", "report_date": "20170412", "code_info": "Lot #: BXHBJD1A, Exp. 10/2018"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0389-2017", "product_description": "Sermorelin Acetate/GHRP (2) & (6) 9 mg/3.15 mg/3.15 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "3,089 kits (number of vials per kit vary by prescription)", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known kit lot code: 05122016@180, 06132016@155, 06232016@147, 07062016@156, 07272016@68, 08232016@24, 09062016@74.  Known vial lot code: 04212016@110, 052412016@76, 05312016@40, 06102016@52, 07152016@56, 08192016@20, 08102016@56."}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "ADD HEPARIN PF 50 Units ONLY TO TPN all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0807-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0533-2017", "product_description": "BLEACHING CREAM 0.1% CREAM, BLEACHING CREAM HQ4%, BLEACHING CREAM-NO HQ, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0363-2017", "product_description": "Inositol/Choline/B-Complex+Leucine+CARN+CHROM+LIDO  (LipoLean), Injectable, 30 mL vial, Compounded by Wells Pharmacy. Ocala, FL", "product_quantity": "433 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 04132016@32, 05062016@4, 05312016@5, 06132016@93, 06282016@36, 08172016@5."}, {"country": "United States", "city": "Little Rock", "address_1": "8821 Knoedl Ct", "reason_for_recall": "Lack of assurance of sterility: Product bags leaking at seam.", "address_2": "", "product_quantity": "370 bags", "code_info": "LOT # 20170506@14, Use By: 08/04/17", "center_classification_date": "20170531", "distribution_pattern": "Nationwide in the USA", "state": "AR", "product_description": "fentaNYL (as citrate) in 0.9% Sodium Chloride injectable,10 mcg per mL, Total Volume 100 mL, Single Dose Container bag, (Total fentanyl Dose 1,000 mcg/100 mL) Preservative Free, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205, NDC 70004-0202-32", "report_date": "20170607", "classification": "Class II", "openfda": {}, "recalling_firm": "SCA Pharmaceuticals", "recall_number": "D-0873-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77314", "termination_date": "20180329", "more_code_info": "", "recall_initiation_date": "20170518", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0323-2017", "product_description": "Ultra Cocktail #2 (Methionine (L) 12.5mg/Inositol 25mg/Choline Chloride 25 mg/Methylcobalamin 300mcg/Carnitine (L) 170mg/Thiamine HCL 20mg/Riboflavin-5-Phosphate Sod 2mg/Pyridoxine HCL 2mg/Folic Acid 2mg/Ascorbic Acid 20mg/Chromium Picolinate 66mcg/Lidocaine HCL 10mg/mL), (30 ML and 10 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "123 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 05192016A (11/15/2016), 08032016B (12/31/2016), 08232016A (12/31/2016), 09292016C (01/31/2017)."}, {"status": "Terminated", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091226"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Mylan Institutional Inc."], "product_ndc": ["51079-208", "51079-209", "51079-210", "51079-211"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["3a398bf9-4f72-46b9-e063-6394a90af2d2"], "spl_set_id": ["7c1083b9-7a20-475d-ba12-4f5d0b53e601"], "package_ndc": ["51079-208-01", "51079-208-20", "51079-209-01", "51079-209-20", "51079-210-01", "51079-210-20", "51079-211-01", "51079-211-03"], "original_packager_product_ndc": ["0378-3950", "0378-3951", "0378-3952", "0378-3953"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "76802", "recalling_firm": "Mylan Institutional, Inc. (d.b.a. UDL Laboratories)", "address_1": "1718 Northrock Ct", "address_2": "", "postal_code": "61103-1201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0622-2017", "product_description": "Atorvastatin Calcium Tablets, 10 mg*, 100-count Unit Dose Tablets (10 x 10) per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.., NDC 51079-208-20", "product_quantity": "1,527 cartons", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.", "recall_initiation_date": "20170321", "center_classification_date": "20170328", "termination_date": "20190315", "report_date": "20170405", "code_info": "Lot #: 3084288, Exp. 07/18", "more_code_info": ""}, {"country": "United States", "city": "Union", "address_1": "675 Rahway Ave", "reason_for_recall": "Labeling: Not elsewhere classified; product labeling lacks a NDC number, net weight information and does not contain the Drug Facts Panel.", "address_2": "", "product_quantity": "2,634 bottles (58 bottles/5mL & 2576 bottles/15 mL)", "code_info": "all lots  Expiration date August 2019", "center_classification_date": "20170524", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Refresh Tears (Carboxymethylcellulose Sodium Solution) 0.5%, Lubricant Eye Drops, Sterile packaged as 1) two 15 mL bottles, USPC Code 784190442214, 2) 4x15 mL and one 5 mL bonus bottles, USPC Code 069886941746, Distributed by Cell Distributors, Union, NJ", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Cell Distributors", "recall_number": "D-0865-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76861", "termination_date": "20190618", "more_code_info": "", "recall_initiation_date": "20170403", "postal_code": "07083-6683", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0324-2017", "product_description": "Ultra Slim Shot (Methionine (L) 25mg/Inositol 50mg/Choline Chloride 50 mg/Methylcobalamin 1mg/Carnitine (L) 170mg/Pyridoxine HCL 2mg/Lidocaine HCL 10mg/mL), (30 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "874 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 06232016C (12/20/2016), 07272016B (12/31/2016), 08232016B (01/31/2017), 10262016D (02/28/2017), 09202016C (03/19/2016)."}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77634", "recalling_firm": "PharMedium Services, Llc", "address_1": "12620 W Airport Blvd Ste 130", "address_2": "N/A", "postal_code": "77478-6200", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0993-2017", "product_description": "Potassium PHOSphate in 5% Dextrose Injection, 7.5 mMol in 100 mL in 150 mL Intravia Bag, Rx Only, PharMEDium Services, LLC 12620 W. Airport Blvd #130 Sugar Land, TX 77478 800-523-7749 Service Code 2K5299 NDC# 61553-299-48", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; media fill failure at manufacturer", "recall_initiation_date": "20170626", "center_classification_date": "20170714", "termination_date": "20200429", "report_date": "20170726", "code_info": "Lot: 171450017D, 8/24/2017"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78320", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-0062-2018", "product_description": "fentanyl as citrate 2 mcg per mL BUPIvacaine HCl 0.125% (Total FentaNYL Dose 500 mcg/250 mL) in 0.9% Sodium Chloride 250 mL Bag, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct, Little Rock, AR 72205. NDC 70004-0231-40", "product_quantity": "116 bags", "reason_for_recall": "Lack Of Assurance Of Sterility.", "recall_initiation_date": "20171019", "center_classification_date": "20171102", "termination_date": "20190501", "report_date": "20171108", "code_info": "Lot: 20170814@20 BUD: 11/12/2017"}, {"status": "Terminated", "city": "North Chicago", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA203952"], "brand_name": ["DUOPA"], "generic_name": ["CARBIDOPA AND LEVODOPA"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-3012"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ENTERAL"], "substance_name": ["CARBIDOPA", "LEVODOPA"], "rxcui": ["1599846", "1599852"], "spl_id": ["df03067f-7374-4da4-852f-827a421a41d2"], "spl_set_id": ["7066d371-dc6a-0d6f-7bed-e5dd4ee912da"], "package_ndc": ["0074-3012-07"], "is_original_packager": [true], "upc": ["0300743012071"], "nui": ["N0000175754", "N0000175755", "N0000193220", "M0370111"], "pharm_class_epc": ["Aromatic Amino Acid Decarboxylation Inhibitor [EPC]", "Aromatic Amino Acid [EPC]"], "pharm_class_moa": ["DOPA Decarboxylase Inhibitors [MoA]"], "pharm_class_cs": ["Amino Acids, Aromatic [CS]"], "unii": ["MNX7R8C5VO", "46627O600J"]}, "product_type": "Drugs", "event_id": "76199", "recalling_firm": "AbbVie Inc.", "address_1": "1 N Waukegan Rd", "address_2": "N/A", "postal_code": "60064-1802", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "TN and IL", "recall_number": "D-0495-2017", "product_description": "Duopa (carbidopa and levodopa enteral suspension), 4.63 mg/20 mg per mL, 100 mL cassette, 7 cassettes per carton, Rx Only, AbbVie Inc., North Chicago, IL 60064 --- NDC 0074-3012-07", "product_quantity": "4021 cartons, 7 100-mL cassettes each", "reason_for_recall": "Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within drug cassettes nearing the end of their refrigerated shelf-life", "recall_initiation_date": "20170113", "center_classification_date": "20170227", "termination_date": "20190315", "report_date": "20170308", "code_info": "Lots:  1055692, Expiration Date (Frozen) 06/01/2018  1057881, Expiration Date (Frozen) 06/02/2018  1060138, Expiration Date (Frozen) 06/13/2018  1060140, Expiration Date (Frozen) 06/15/2018  1061258, Expiration Date (Frozen) 06/17/2018  1061262, Expiration Date (Frozen) 06/30/2018  1063033, Expiration Date (Frozen) 07/14/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76457", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to  a sold customer in FL.", "recall_number": "D-0482-2017", "product_description": "Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged by RemedyRepack, Indiana, PA 15701, NDC 52125-0764-02", "product_quantity": "630 pills (21 bottles x 30 pills per HDPE bottle)", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20170207", "center_classification_date": "20170218", "termination_date": "20170505", "report_date": "20170301", "code_info": "Lot #  B0129373-021916; Exp. 10/17    00591-0900-30  Original NDC  52125-0764-02  RemedyRepack NDC"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0375-2017", "product_description": "MIC/Chromium/B12(M) Injectable, 25 mg/50 mg/50 mg/25 mcg/1 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "648 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 03302016@8, 04152016@5, 05032016@15, 05262016@24, 06142016@1, 07202016@55."}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78320", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-0060-2018", "product_description": "HYDROmorphone HCL 1 mg per mL in 0.9% Sodium Chloride 25 mL Fill in 30 mL single-dose syringe (Total Dose Hydromorphone 25 mg/25 mL)  Rx Only SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR NDC 70004-0303-17", "product_quantity": "128 syringes", "reason_for_recall": "Lack Of Assurance Of Sterility.", "recall_initiation_date": "20171019", "center_classification_date": "20171102", "termination_date": "20190501", "report_date": "20171108", "code_info": "Lot: 20170808@52 BUD: 11/06/2017"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0410-2017", "product_description": "Trimix with Atropine Injectable 30 mg/3 mg/300 mcg/0.2 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "3 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 07192016@8."}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76443", "recalling_firm": "L. Perrigo Company", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within United States", "recall_number": "D-0503-2017", "product_description": "Salicylic Acid Shampoo, 6%, 177 mL bottle, Rx only, Manufactured By Perrigo Yeruham, Israel, Distributed By Perrigo Allegan, MI 49010, NDC 45802-237-01,   UPC 3 45802-237-01 9.", "product_quantity": "10,656 units total for both products", "reason_for_recall": "Failed Impurities/Degradation Specifications: The API for these products had an out of specification result for an organic impurity.", "recall_initiation_date": "20170213", "center_classification_date": "20170301", "termination_date": "20170926", "report_date": "20170308", "code_info": "Lot #: 099534, Exp. 07/18; 099512 Exp. 06/18.", "more_code_info": ""}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.", "address_2": "", "product_quantity": "550 syringes", "code_info": "Lot: 4/20/17 0307 265-86361S, BUD 6/19/17; 4/26/17 0732 265-86361S, BUD 6/25/17; 4/28/17 0215 265-86361S, BUD 6/27/17; 5/2/17 0310 248-86361S, BUD 7/1/17; 5/4/17 1422 248-86361S, BUD 7/3/17; 5/12/17 0841 248-86361S, BUD 7/11/17; 5/18/17 0206 250-86361S, BUD 7/17/17", "center_classification_date": "20171220", "distribution_pattern": "Nationwide in the USA to hospitals and medical facilities.", "state": "TX", "product_description": "NitroGlycerin (2 mg/10 mL in 5% Dextrose Inj, USP QS 10mL (200 mcg per mL), 10 mL Sterile single dose syringe, packaged in 5 x 5 (TWENTY FIVE) syringes per box, Rx only, Advanced Pharma, 9265 Kirby Dr., Houston, TX  77054, NDC 15082-863-61.", "report_date": "20171227", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0119-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77503", "termination_date": "20190403", "more_code_info": "", "recall_initiation_date": "20170609", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Pithampur", "state": "N/A", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "77323", "recalling_firm": "Lupin Limited (Unit 1)", "address_1": "Unit 1, Plot 2, SEZ, Phase II,", "address_2": "Misc Zone Apparel Park, Dist. Dhar", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1093-2017", "product_description": "Mibelas 24 Fe (Norethindrone acetate and Ethinyl estradiol 1 mg/0.02 mg chewable and ferrous Fumarate 75 mg) Tablets, wallet of 28 tablets (NDC 68180-911-11), Carton of 3 wallets (NDC 68180-911-13), Rx Only, Manufactured by: Lupin Limited, India, Distributed by Lupin Pharmaceuticals, Inc., Baltimore, MD, 21202", "product_quantity": "24,652 tablets", "reason_for_recall": "Contraceptive Tablets Out of Sequence- First 4 pills of the packet are brown, instead of the last four pills and the expiry/lot was not printed on the package.", "recall_initiation_date": "20170516", "center_classification_date": "20170815", "termination_date": "20190530", "report_date": "20170823", "code_info": "Batch Number L600518; Exp. 05/18"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0348-2017", "product_description": "Chorionic Gonadotropin, Lyophilized, 5,000 unit Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "5277 kits (number of vials per kit vary by prescription)", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known kit lot code: 04142016@75, 04252016@52, 05042016@143, 05042016@158, 06092016@169, 06242016@158, 08022016@154, 08112016@56, 08252016@82, 09082016@41.  Known vial lot code: 04062016@7, 04182016@49, 04292016@80, 04282016@43, 06012016@44, 06152016@57, 07132016@68, 08042016@35, 08192016@45, 08242016@33"}, {"status": "Terminated", "city": "New Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77398", "recalling_firm": "Spectrum Laboratory Products, Inc.", "address_1": "755 and 769 Jersey Ave", "address_2": "N/A", "postal_code": "08901-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0881-2017", "product_description": "Estradiol (17-B-Estradiol; Estra-1,3,5(10)-triene-3, 17B-diol; Oestradiol) Plant Base, Micronized, U.S.P active pharmaceutical ingredient, packaged in 1g, 5g, 25g, 6 x 25g, and 100g containers, Rx only, Spectrum Chemical Mfg. Corp, Gardena, CA  90248, New Brunswick, NJ  08901, Product code E1435.", "product_quantity": "48 containers", "reason_for_recall": "CGMP Deviations: these repackaged and redistributed products are being recalled due to a recall notice from the active pharmaceutical ingredient manufacturer for deviations from current Good Manufacturing Practices that were found during a recent FDA inspection.", "recall_initiation_date": "20170413", "center_classification_date": "20170602", "termination_date": "20190221", "report_date": "20170614", "code_info": "Lot #: 2FH0257, Exp 09/30/2017;  2GA0254, Exp 03/24/2018"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77319", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US and Puerto Rico", "recall_number": "D-0869-2017", "product_description": "Nystatin Oral Suspension, USP, 100,000 units/mL, packaged in a) 2 fl.oz. (60mL) bottles (NDC 66689-008-02), and 500,000 units/5mL individual unit dose cup (NDC 66689-037-01) packaged in b) 50 count unit dose cups/case (NDC 66689-037-50) and c) 100 count unit dose cups/case (NDC 66689-037-99) Rx only, Manufactured by: VistaPharm, Largo, FL 33771.", "product_quantity": "2,208,500 cups/18696 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Presence of an impurity peak that exceeds approved specification.", "recall_initiation_date": "20170517", "center_classification_date": "20170531", "termination_date": "20200113", "report_date": "20170607", "code_info": "a) Lot #: 431300, Exp. 01/2018;   b) Lot #: 434000, 432500, Exp. 07/2017;462200, Exp. 02/2018  c) Lot #: 443800, 445500, Exp. 09/2017; 460500, 461500, Exp. 01/2018.", "more_code_info": ""}, {"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77634", "recalling_firm": "PharMedium Services, Llc", "address_1": "12620 W Airport Blvd Ste 130", "address_2": "N/A", "postal_code": "77478-6200", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0990-2017", "product_description": "Potassium PHOSphate in 0.9% Sodium Chloride Injection, 40 mMol in 250 mL in 250 mL Intravia Bag, Rx Only, PharMEDium Services, LLC 12620 W. Airport Blvd #130 Sugar Land, TX 77478 800-523-7749 Service Code 2K5301 NDC# 61553-301-11", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; media fill failure at manufacturer", "recall_initiation_date": "20170626", "center_classification_date": "20170714", "termination_date": "20200429", "report_date": "20170726", "code_info": "Lots: 171220007S Exp. 7/31/2017, 171280129S Exp. 8/7/2017, 171320112S Exp. 8/13/2017, 171590010S Exp. 9/7/2017"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0333-2017", "product_description": "Nicotinamide Adenine Dinucleotide (NADH) - Lyophilized (P.F.) 100 mg Injectable, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "Unknown", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.       Known lot code: 03302016@13, 06302016@95, 08082016@58."}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76105", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide and Puerto Rico", "recall_number": "D-0478-2017", "product_description": "Lisinopril tablets, 5 mg, 1000-count bottle, Rx only, Manufactured for Accord Healthcare, Inc., Durham, NC 27703, NDC 16729-376-17", "product_quantity": "12896 bottles", "reason_for_recall": "Failed tablet/capsule specification: missing break line on the 5mg tablet.", "recall_initiation_date": "20161220", "center_classification_date": "20170216", "termination_date": "20170802", "report_date": "20170222", "code_info": "Lot # T04483, T04484, Exp 2/18; T06028, Exp 4/18; T08423, Exp 5/18", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77862", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1163-2017", "product_description": "Quillivant XR methylphenidate HCl, for extended-release oral suspension, 600 mg/120 mL total volume (When constituted with 105 mL of water, 25 mg/5 mL (5 mg/mL) when reconstituted,   Rx Only, Distributed by Nextwave Pharmaceuticals, Inc. A subsidiary of Pfizer Inc., New York, NY 10017, Manufactured by Tris Pharma, Inc., Monmouth Junction, NJ 08852, NDC 24478-200-20.", "product_quantity": "14,712 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20170804", "center_classification_date": "20170915", "termination_date": "20190411", "report_date": "20170927", "code_info": "Lot # 03216048A, Exp.  05/18", "more_code_info": ""}, {"status": "Terminated", "city": "Bristol", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75982", "recalling_firm": "Gentell, Inc", "address_1": "2701 Bartram Rd", "address_2": "N/A", "postal_code": "19007-6810", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "United States", "recall_number": "D-0242-2017", "product_description": "Gentell  Hydrogel Ag Saturated Gauze, 2\"x2\"(NDC 61551-112-20), 4x4(NDC 61554-114-24) and 4\"x8\"(NDC 61554-118-28), Manufactured by: Gentell, 2701 Bartram Road, Bristol, PA 19007", "product_quantity": "3,000 gauzes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20161215", "center_classification_date": "20170102", "termination_date": "20180216", "report_date": "20170111", "code_info": "Gentell Hydrogel AG 2X2 (Gen-11260)  Lot #: 1121615, 1121713, 1122215; Exp. 11/18    Gentell Hydrogel AG 4X4 (Gen-11460)  Lot #: 1123315, 1125215, 1126515; Exp. 11/18    Gentell Hydrogel AG 4X8 (Gen-11860)  Lot #: 1127315, 1130015, 1133615; Exp. 11/18"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0364-2017", "product_description": "Leucine/Isoleucine/Valine 10 mg/10 mg/5 mg/5 mg/mL Injectable, 30 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "189 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 04062016@3, 04252016@4, 05172016@4, 06162016@6, 07212016@8."}, {"status": "Ongoing", "city": "Brentwood", "state": "MO", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA019430"], "brand_name": ["EPIPEN"], "generic_name": ["EPINEPHRINE"], "manufacturer_name": ["Viatris Specialty LLC"], "product_ndc": ["49502-500", "49502-501"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["EPINEPHRINE"], "rxcui": ["727316", "727347", "727386", "1870207"], "spl_id": ["81569d26-e9b3-4c1d-ac34-8a4cf5b4a98b"], "spl_set_id": ["7560c201-9246-487c-a13b-6295db04274a"], "package_ndc": ["49502-500-01", "49502-500-02", "49502-500-92", "49502-501-01", "49502-501-02", "49502-501-92"], "is_original_packager": [true], "nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_cs": ["Catecholamines [CS]"], "unii": ["YKH834O4BH"]}, "product_type": "Drugs", "event_id": "76789", "recalling_firm": "Meridian Medical Technologies a Pfizer Company", "address_1": "2555 Hermelin Dr", "address_2": "", "postal_code": "63144-2504", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide and Puerto Rico, Argentina, Austria, Australia, Belgium, Chile, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Ireland, Italy, Japan, Latvia, Lithuania, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Saudi Arabia, Singapore, Slovakia, Slovenia, Sweden, Switzerland, Taiwan, Thailand,  United Kingdom.  There has been no U.S. government or military distribution.", "recall_number": "D-0690-2017", "product_description": "EpiPen 2-Pak (Epinephrine) Auto-Injectors 0.3 mg, Rx only, Manufactured for Mylan Specialty L.P., Morgantown WV 26505 by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company; NDC 49502-500-02 ---- ALSO LABELED OUTSIDE THE US AS ---- Epipen Auto-Injector 0.3 mg -Bright Stock labeled for multiple countries- manufactured for Mylan by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company.", "product_quantity": "373,960 2-paks (U.S.) ; 331,738 auto-injectors (O.U.S.)", "reason_for_recall": "Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication", "recall_initiation_date": "20170312", "center_classification_date": "20170428", "report_date": "20170510", "code_info": "US:   lot 5GM631, exp. April 2017;  lot 5GM640, exp. May 2017;  lot 6GM072, exp. Sep 2017;  lot 6GM082, exp. Sep 2017;  lot 6GM088, exp. Oct 2017;   lot 6GM087, exp. Oct 2017;   lot 6GM198, exp. Oct 2017;   lot 6GM081, exp. Sep 2017;  lot 6GM091, exp. Oct 2017;  lot 6GM199, exp. Oct 2017:     INTERNATIONAL:  lot 5FA665, exp. April 2017;   lot 5GU763, exp. May 2017;   lot 6FA293, exp. Oct 2017;  lot 6FA292, exp. Oct 2017;  lot 6GH294, exp. Oct 2017.", "more_code_info": ""}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76636", "recalling_firm": "Amerisource Health Services", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0520-2017", "product_description": "GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21), Individual dose (NDC 68084-395-11), Rx Only, Packaged and Distributed by American Health Packaging, Columbus, Ohio 43217, NDC 68084-295-21", "product_quantity": "19,393 cartons (581,790 extended release tablets)", "reason_for_recall": "Failed dissolution specifications: Glipizide 2.5 mg ER  Tablets exceeded  dissolution specification rates for the 10 hour testing point.", "recall_initiation_date": "20170203", "center_classification_date": "20170314", "termination_date": "20180301", "report_date": "20170322", "code_info": "Lot #160133, 160549 Exp. 08/17  Lot #162006; Exp. 09/17  Lot #163348A, 163348B; Exp. 10/17"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78063", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-0036-2018", "product_description": "Oxytocin 10 units added to 500 mL Lactated Ringer's Injection USP in 500 mL bag ,Rx Only , Compounded by PharMEDium Services, LLC. 12620 W. Airport Blvd. #130, Sugar Land, TX 77478, NDC# 71019-237-01", "product_quantity": "1308 bags", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20170901", "center_classification_date": "20171025", "termination_date": "20200124", "report_date": "20171101", "code_info": "All unexpired lots."}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Norepinephrine Bitartrate all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0827-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0331-2017", "product_description": "Phenylephrine HCl Injectable, 1 mg/mL (0.1%), 5 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "1,968 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot codes: 03292016@3, 04202016@4, 05162016@6, 06102016@9,  07202016@44, 08032016@38"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0361-2017", "product_description": "Glutathione 200 mg/mL Injectable, 30 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "148 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 07252016@46, 08112016@19."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77822", "recalling_firm": "Akorn Inc", "address_1": "1925 W Field Ct", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1089-2017", "product_description": "Halyard 24-Hour Oral Care Kit q2, contains 2x15 mL Unit Dose Cups 0.12% Chlorhexidine Gluconate Oral Rinse.  Manufactured by Halyard Health Inc., 5405 Windward Parkway, Alpharetta, GA 30004. Distributed by Halyard Sales, LLC Alpharetta, GA 30004. REF # 97012", "product_quantity": "40,978 unit dose cups", "reason_for_recall": "Crystallization with subpotent out of  specification assay results for chlorhexidine.", "recall_initiation_date": "20170712", "center_classification_date": "20170814", "termination_date": "20180619", "report_date": "20170823", "code_info": "Lots: 0202623109, 0202623110, 0202623111, 0202630207, 0202630208, 0202630209, EXP 06-2018; 0202642227, 0202642228, 0202647413, 0202647414, 0202653433, 0202653434, EXP 07-2018."}, {"status": "Terminated", "city": "Jamul", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "76109", "recalling_firm": "Pacific Medical Solutions", "address_1": "13967 Campo Rd Ste 102", "address_2": "N/A", "postal_code": "91935-3232", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States and Mexico", "recall_number": "D-0505-2017", "product_description": "Nano PNC Water, packaged in amber glass bottles, Rx only, ICRPstudy.com, Immune Cellular Restoration Program.", "product_quantity": "N/A", "reason_for_recall": "Marketed without an Approved NDA/ANDA and non-sterility:  NANO PNC Water by nebulizer was sampled and found to contain variovorax paradoxus.", "recall_initiation_date": "20161213", "center_classification_date": "20170301", "termination_date": "20170328", "report_date": "20170308", "code_info": "None", "more_code_info": ""}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Bupivacaine HCl in 0.9% Sodium Chloride all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0794-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0253-2017", "product_description": "BiMix Phentolamine/Papaverine 2 mg/30 mg/mL (1 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "2 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.     Known lot codes (Exp Date): 09302016D (11/14/2016)."}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA076255"], "brand_name": ["OLANZAPINE"], "generic_name": ["OLANZAPINE"], "manufacturer_name": ["Dr. Reddy's Laboratories Ltd."], "product_ndc": ["55111-163"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OLANZAPINE"], "rxcui": ["200034"], "spl_id": ["ba26436d-7009-476f-23b0-45676a0e7805"], "spl_set_id": ["9a57a63e-f856-aafa-037a-c08f2fea6496"], "package_ndc": ["55111-163-30", "55111-163-01", "55111-163-05", "55111-163-79", "55111-163-78"], "is_original_packager": [true], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["N7U69T4SZR"]}, "product_type": "Drugs", "event_id": "75442", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide", "recall_number": "D-0468-2017", "product_description": "Olanzapine tablets, USP, 2.5 mg, packaged in a 30-count bottle, Rx only, Mfd: By: Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-163-30", "product_quantity": "5,904 bottles", "reason_for_recall": "Failed impurities/degradation specifications: due to out-of-specification result for the Related Substance Compound C (Impurity 6 - N-Oxide at the 18 month stability station.", "recall_initiation_date": "20161013", "center_classification_date": "20170203", "termination_date": "20170724", "report_date": "20170215", "code_info": "C500202"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78320", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-0064-2018", "product_description": "morphine sulfate 1 mg per mL in 0.9% Sodium Chloride  a) Total Volume 100 mL in Single Dose CADD Cassette (Total morphine Dose 100 mg per 100 mL) (NDC 70004-0100-63) b) Total Volume 50 mL in Single Dose Syringe (Total morphine Dose 50 mg / 50 mL) (NDC 70004-0100-22) Rx Only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205", "product_quantity": "a) 60 bag inside rigid translucent plastic case (CADD)  b) 238 bag", "reason_for_recall": "Lack Of Assurance Of Sterility.", "recall_initiation_date": "20171019", "center_classification_date": "20171102", "termination_date": "20190501", "report_date": "20171108", "code_info": "Lots: a) 20170905@24 BUD: 12/04/2017 b) 20170901@25 BUD: 11/30/2017"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0365-2017", "product_description": "Methylcobalamin 1,000 mcg/mL Injectable, a) 10 mL vial and b) 30 mL vial,  Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "a) 499 vials b) 1214 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     a) Known lot code: 04062016@5, 05172016@1, 06162016@2, 07202016@47, 08222016@6    b) Known lot code: 04052016@1, 05032016@1, 05182016@1, 05262016@32, 06162016@13, 06232016@74, 07012016@18, 08092016@6, 09062016@33"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0407-2017", "product_description": "Tri 1 (PAP/PHEN/ATROPINE) NR Injectable, 3.6 mg/0.4 mg/0.04 mg/mL,  a) 2 mL  and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "a) 257 vials and b) 460 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     a) Known lot code: 04072016@10, 05102016@18, 06232016@12, 08182016@26    b) Known lot code: 04122016@19, 05042016@18, 06142016@43, 07122016@40, 07262016@47."}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76513", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States and Puerto Rico", "recall_number": "D-0511-2017", "product_description": "Risedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per blister (NDC 0093-5509-19), packaged in 4 blisters per carton (NDC 0093-5509-44), Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA  19454.", "product_quantity": "25,916 cartons", "reason_for_recall": "Failed Dissolution Specifications: low out of specification dissolution results found during stability testing.", "recall_initiation_date": "20170217", "center_classification_date": "20170303", "termination_date": "20180205", "report_date": "20170315", "code_info": "Lot # 34025762A, Exp 06/17"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "2 vials", "code_info": "Lot # t11-16-2016@90, Exp 4/19/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "PGE1/PAP 10/30 5ML MDV MCG/MG/ML INJ, Injection,  10mg/30mg/mL, Rx only, 5mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0734-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "2 vials", "code_info": "Lot # t01-05-2017@110, Exp 6/17/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "QUAD MIX 1/30/0.5/0.1 5ML MDV MCG/MG/MG/MG/ML INJ, Injection, 1mcg/30mg/0.5mg/0.15mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0754-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "25 vials", "code_info": "Lot # t01-10-2017@115, Exp 7/5/2017.", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "TRI MIX 20/20/1 5ML MDV MCG/MG/MG/ML INJ, Injection, 20mcg/20mg/1mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0742-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77450", "recalling_firm": "L. Perrigo Company", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "IL", "recall_number": "D-0925-2017", "product_description": "Walgreens Daytime and Nighttime Cold & Flu, packaged in combo pack of two plastic 12FL OZ (355 mL) bottles connected by one paper sleeve, TOTAL 24 FL OZ (1.5 pt)(710 mL), OTC, Distributed by: Walgreen CO., 200 Wilmot Rd., Deerfield, IL 60015", "product_quantity": "1,998 combo packs", "reason_for_recall": "Labeling: Label Mix-Up - This product is being recalled due to an incorrect product sleeve on the product twin pack. The incorrect product sleeve is for \u001cDay-Night Cold and Flu\u001d whereas the batch contains Day-Night Cough Liquid.", "recall_initiation_date": "20170605", "center_classification_date": "20170628", "termination_date": "20171207", "report_date": "20170705", "code_info": "Lot #: 6MV0944, Exp 10/18"}, {"status": "Terminated", "city": "Edmond", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77064", "recalling_firm": "Qualgen", "address_1": "14844 Bristol Park Blvd", "address_2": "N/A", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0890-2017", "product_description": "Estradiol 22 mg pellet 99.5% Estradiol USP, .5% Stearic Acid NF, in 1 count, 12 count, and 30 count bottles, Sterile Office Use Only, For Subcutaneous Use Only Rx Only, Manufactured by: Qualgen 14844 Bristol Park Blvd Edmond, OK 73013 NDC 69761-022-01", "product_quantity": "1,666 pellets.", "reason_for_recall": "CGMP deviations- Lack of Quality Assurance", "recall_initiation_date": "20170419", "center_classification_date": "20170607", "termination_date": "20210924", "report_date": "20170614", "code_info": "Lot # B128; Exp. 11/1/17  Lot # B075; Exp. 08/3/17"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78320", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "8821 Knoedl Ct", "address_2": "N/A", "postal_code": "72205-4600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-0059-2018", "product_description": "SUCcinylcholine 20 mg per mL, Total Volume 10 mL in single-dose syringe, (SUCcinylcholine 200 mg / 10 ml) Rx Only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR NDC 70004-0910-29", "product_quantity": "1248 syringes", "reason_for_recall": "Lack Of Assurance Of Sterility.", "recall_initiation_date": "20171019", "center_classification_date": "20171102", "termination_date": "20190501", "report_date": "20171108", "code_info": "Lot: 20170726@35 BUD: 10/24/2017"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "240 mL", "code_info": "Lot # 02-01-2017@38, Exp 4/30/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "HYDROXO-B12 INH PF GV  5MG/ML SOLN, Inhalation Solution, 5mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0723-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Corpus Christi", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76235", "recalling_firm": "MOORE'S COMPOUNDING PHARMACY", "address_1": "5945 McArdle Rd Ste 101", "address_2": "N/A", "postal_code": "78412-3491", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "TX", "recall_number": "D-0488-2017", "product_description": "Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules, 90 count bottles, Rx only, Moore's Pharmacy Compounding, Corpus Christi, TX", "product_quantity": "90 capsules", "reason_for_recall": "Superpotent Drug and Subpotent Drug; potency failures obtained", "recall_initiation_date": "20160912", "center_classification_date": "20170221", "termination_date": "20170517", "report_date": "20170301", "code_info": "2016-08-22:37@28, exp 2/18/2017"}, {"status": "Terminated", "city": "Marietta", "state": "GA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA205327"], "brand_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "generic_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "manufacturer_name": ["Trigen Laboratories, LLC"], "product_ndc": ["13811-706", "13811-709", "13811-707", "13811-708", "13811-710"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "rxcui": ["1091155", "1091170", "1091185", "1091210", "1995461"], "spl_id": ["54f7316b-8a84-4145-aecf-f380afbf261b"], "spl_set_id": ["c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f"], "package_ndc": ["13811-709-10", "13811-706-10", "13811-707-10", "13811-708-10", "13811-710-10", "13811-710-30"], "is_original_packager": [true], "upc": ["0313811706109", "0313811709100", "0313811708103", "0313811707106"], "unii": ["4B3SC438HI"]}, "product_type": "Drugs", "event_id": "78764", "recalling_firm": "Osmotica Pharmaceutical Corp", "address_1": "895 Sawyer Rd", "address_2": "", "postal_code": "30062-2257", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0110-2018", "product_description": "Methylphenidate Hydrochloride Extended-release Tablets, USP 27 mg, 100-count bottles,  Rx Only, Trigen Laboratories, LLC. Bridgewater, NJ 08807, NDC 13811-707-10", "product_quantity": "10064 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20171218", "center_classification_date": "20171220", "termination_date": "20190501", "report_date": "20171227", "code_info": "Lot #: 170027A, Exp. 02/2019", "more_code_info": ""}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "3 vials", "code_info": "Lot # t12-28-2016@113, Exp 6/27/2017.", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "5-MTHF 10ML SDV (CALIF) 5MG/ML INJ, Injection 5mg/mL, Rx only, 10mL Glass /Single Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0709-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Morristown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77484", "recalling_firm": "Bayer HealthCare Pharmaceuticals, Inc.", "address_1": "36 Columbia Rd", "address_2": "N/A", "postal_code": "07960-4526", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1050-2017", "product_description": "Alka-Seltzer Extra Strength (500 mg Aspirin (NSAID), 1985 mg Analgesic Sodium bicarbonate/Antacid, 1000 mg Anhydrous Citric Acid) Effervescent Tablets, 24-count carton, Made in Germany, Distributed by Bayer HealthCare, LLC Whippany, NJ 07981,  UPC 016500044048", "product_quantity": "24,672 24-count cartons", "reason_for_recall": "Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.", "recall_initiation_date": "20170330", "center_classification_date": "20170801", "termination_date": "20200108", "report_date": "20170809", "code_info": "BTAHDG0; Exp. 04/19"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0548-2017", "product_description": "HYDROQUINONE SOLUTION  in all strengths including 4%, 28%,  Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076658"], "brand_name": ["FLUCONAZOLE"], "generic_name": ["FLUCONAZOLE"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-143", "55111-144", "55111-145", "55111-146"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FLUCONAZOLE"], "rxcui": ["197698", "197699", "197700", "197701"], "spl_id": ["69e67aa4-a859-7ab0-79df-d9bf8489998d"], "spl_set_id": ["d7fa1d79-4cd3-4a55-b74b-b31e82e616a3"], "package_ndc": ["55111-143-30", "55111-143-01", "55111-143-05", "55111-143-79", "55111-143-78", "55111-144-30", "55111-144-01", "55111-144-05", "55111-144-79", "55111-144-78", "55111-145-71", "55111-145-12", "55111-146-30", "55111-146-01", "55111-146-05", "55111-146-79", "55111-146-78"], "is_original_packager": [true], "upc": ["0355111145127"], "nui": ["N0000175487", "M0002083", "N0000182140", "N0000182141", "N0000185504"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_moa": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "unii": ["8VZV102JFY"]}, "product_type": "Drugs", "event_id": "76122", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0450-2017", "product_description": "Flucanozole Tablets, USP, 100 mg, a) 30 count (NDC 55111-144-30) and b) 100 count (NDC 55111-144-01) bottles, Rx Only, Mfd. by: Dr. Reddy's Laboratories, Bachupally 500 090 India", "product_quantity": "a) 42,984 and b) 7,764 bottles", "reason_for_recall": "Failed Dissolution Specifications; 18 month stability time point", "recall_initiation_date": "20161228", "center_classification_date": "20170130", "termination_date": "20171019", "report_date": "20170208", "code_info": "a) 30 count C500224, exp 12/2016, C500846, exp 01/2017  b) 100 count C500224, exp 12/2016, exp 12/2016, C501608, exp 02/2017 and C503655, exp 04/2017", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77374", "recalling_firm": "Pharmedium Services Llc", "address_1": "150 N Field Dr", "address_2": "N/A", "postal_code": "60045-4847", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0932-2017", "product_description": "Ropivacaine HCl 0.2% 500 mL Total Volume in an ON-Q Pump in 0.9% Sodium Chloride Injection in 400 mL, Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land, TX 77478, NDC: 61553-258-25", "product_quantity": "147 I.V. pumps", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date", "recall_initiation_date": "20170215", "center_classification_date": "20170702", "termination_date": "20200113", "report_date": "20170712", "code_info": "Lot: 170270192s  Lot: 170330167s  Lot: 170320087s Ex.: 01/01/1900"}, {"status": "Terminated", "city": "Ringwood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78098", "recalling_firm": "Inopak Ltd", "address_1": "24 Executive Pkwy", "address_2": "N/A", "postal_code": "07456-1430", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "nationwide", "recall_number": "D-0003-2018", "product_description": "Mild Healthcare Antibacterial Hand Soap, 6% P.C.M.X., 1000 mL and 2000 mL Disc Pump,  800 mL Universal Valve, and 1 gallon bottles, Inopak. Ltd, Ringwood, NJ 07456", "product_quantity": "N/A", "reason_for_recall": "GMP Deviations; potential bacterial contamination may have been introduced to products through a contaminated diaphragm pump.", "recall_initiation_date": "20170823", "center_classification_date": "20171004", "termination_date": "20200420", "report_date": "20171011", "code_info": "Batch Numbers \u0013 6749, 6909", "more_code_info": ""}, {"status": "Terminated", "city": "Oberasbach", "state": "N/A", "country": "Germany", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77840", "recalling_firm": "Linde Eckstein Gmbh + Co KG", "address_1": "Flurstrasse 27a-35", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed throughout the United States", "recall_number": "D-1102-2017", "product_description": "Make Up Transparent sand (Titanium Dioxide) SPF 10 liquid make-up, 1 oz. Net Wt. 30 ml bottle, Art. 03220, Made in Germany, Doctor Eckstein, Linde Eckstein GMBH Co. Kg, 90522 Oberasbach, Germany, UPC 4 035219 032203.", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.", "recall_initiation_date": "20170717", "center_classification_date": "20170817", "termination_date": "20180228", "report_date": "20170823", "code_info": "Lot #: 300817, Exp 08/30/2017; 291217, Exp 12/29/2017; 010918, Exp 09/01/2018."}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0419-2017", "product_description": "Tri-Test 200 (CEP 100-75-25) Injectable, 200 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "550 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 04122016@4, 05042016@3, 06012016@8, 06212016@5, 07252016@22."}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77869", "recalling_firm": "The Harvard Drug Group", "address_1": "17177 N Laurel Park Dr Ste 233", "address_2": "", "postal_code": "48152-3951", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1122-2017", "product_description": "Rugby Aller-chlor (Chlorpheniramine Maleate Syrup, USP), 2 mg, 4 fl. oz. (120 mL) plastic bottles, Distributed by:  Rugby Laboratories 17177 N. Laurel Park Drive, Suite 233, Livonia, MI 48152 USA --- NDC: 0536-1025-47", "product_quantity": "4,715 bottles", "reason_for_recall": "Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination", "recall_initiation_date": "20170802", "center_classification_date": "20170824", "termination_date": "20240716", "report_date": "20170830", "code_info": "Item # 370339, all lots", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0544-2017", "product_description": "TRICHLOROACETIC ACID SOLUTION in all strengths including: 10%, 12%, 15 %,  20%, 35%, 70%, and 85%, TRICHLOROCETIC ACID 10%/ LACTIC ACID 12%, TRICHLOROCETIC ACID 6%/LACTIC ACID 12%, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77191", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0906-2017", "product_description": "Potassium CHLORide added to 0.9% Sodium Chloride, 30mEq 100 mL Bag, Service Code 2K5824, NDC# 61553-0824-48, Total Volume 100.00 mL  incorrectly labeled as 115.00 mL, Rx Only, PharMEDium Services, LLC, 6100 Global Drive, Memphis, TN 38141", "product_quantity": "216 bags", "reason_for_recall": "Labeling: Not Elsewhere Classified: Incorrect volume printed on the product label.", "recall_initiation_date": "20170217", "center_classification_date": "20170612", "termination_date": "20170613", "report_date": "20170621", "code_info": "Lot Numbers:  70090135M, 2/27/2017; 170250101M, 3/15/2017; 170030011D, 4/4/2017; 170040078D, 4/5/2017; 170310012D, 5/2/2017; 170400046D, 5/11/2017;"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0376-2017", "product_description": "MIC+B12(M)+Carnitine 12.5 mg/50 mg/100 mg/1 mg/50 mg/mL Injectable, 30 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "159", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 03252016@5, 04192016@8, 05242016@15, 06222016@28, 08102016@2."}]